Cystatin C as an adjunct to HbA1c may prove useful in predicting the development of diabetic complications in children and adolescents with type 1 diabetes
Open Access
- 18 April 2024
- journal article
- research article
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 23 (1) , 1251-1257
Abstract
Purpose: Complications from diabetes mellitus can occur over time and although glycosylated hemoglobin (HbA1c) is a good biomarker for glycaemic control, other factors also contribute to the development of complications in type 1 diabetes. More markers able to identify the risk of complications are needed. This study aimed to investigate plasma levels of FGF21, Cystatin C, lipocalin-2, and MMP-9 in children and adolescents with different duration of type 1 diabetes and possible correlation to HbA1c to identify potential biomarkers of future complication development. Methods: Patients (n = 244, 0–18 years) with type 1 diabetes, at Helsingborg’s Hospital, Sweden, were included in this study. Circulating levels of FGF21, Cystatin C, lipocalin-2, and MMP-9 were investigated in plasma using automated ELISA with the ELLA™ system and standardised controls. Results: Cystatin C levels were elevated in patients with diabetes duration longer than 5 years (P < 0.001). HbA1c and Cystatin C levels were inversely correlated for all participants (rs = − 0.23, CI95: −0.35-−0.10; P < 0.001). A stepwise multiple regression analysis showed that HbA1c (P < 0.001) and Cystatin C (P = 0.03) were associated to the duration of diabetes at sampling while MMP-9, lipocalin-2, and FGF21 did not reach statistical significance. Conclusion: In conclusion, Cystatin C levels were higher in patients with diabetes duration longer than 5 years, and inverse correlation was found between HbA1c and Cystatin C levels as well as duration of diabetes. Cystatin C may prove useful as an adjunct to HbA1c in predicting eventual development of diabetic complications.Keywords
Funding Information
- Lund University
This publication has 29 references indexed in Scilit:
- Association between lipocalin-2 levels and diabetic retinopathy in patients with overweight/obese type 2 diabetes mellitusIrish Journal of Medical Science (1971 -), 2023
- Changes in early optical coherence tomography angiography among children and adolescents with type 1 diabetes: Relation to fibroblast growth factor 21Diabetes/Metabolism Research and Reviews, 2023
- HbA1c levels and circulating inflammatory proteins at onset of type 1 diabetes in children and adolescentsJournal of Diabetes & Metabolic Disorders, 2022
- Serum neutrophil gelatinase-associated lipocalin as a potential biomarker of diabetic kidney disease in patients with childhood-onset type 1 diabetesJournal of the Formosan Medical Association, 2022
- The serum fibroblast growth factor 21 is correlated with retinopathy in patients with type 2 diabetes mellitusDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021
- Association between serum fibroblast growth factor 21 and diabetic nephropathyMetabolism, 2012
- Role of the hemopexin domain of matrix metalloproteinases in cell migrationJournal of Cellular Physiology, 2008
- Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—A meta-analysisClinical Biochemistry, 2007
- Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathyClinica Chimica Acta, 2006
- MT1‐MMP: A potent modifier of pericellular microenvironmentJournal of Cellular Physiology, 2005